chr1-236686695-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001103.4(ACTN2):​c.22G>T​(p.Val8Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000000707 in 1,414,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V8M) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

ACTN2
NM_001103.4 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.05
Variant links:
Genes affected
ACTN2 (HGNC:164): (actinin alpha 2) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a muscle-specific, alpha actinin isoform that is expressed in both skeletal and cardiac muscles. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.18866915).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ACTN2NM_001103.4 linkuse as main transcriptc.22G>T p.Val8Leu missense_variant 1/21 ENST00000366578.6 NP_001094.1 P35609-1
ACTN2NM_001278343.2 linkuse as main transcriptc.22G>T p.Val8Leu missense_variant 1/21 NP_001265272.1 P35609-2
ACTN2NR_184402.1 linkuse as main transcriptn.197G>T non_coding_transcript_exon_variant 1/23

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ACTN2ENST00000366578.6 linkuse as main transcriptc.22G>T p.Val8Leu missense_variant 1/211 NM_001103.4 ENSP00000355537.4 P35609-1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD3 exomes
AF:
0.00000457
AC:
1
AN:
218624
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
119668
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000336
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.07e-7
AC:
1
AN:
1414632
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
703874
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000250
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 16, 2023The p.V8L variant (also known as c.22G>T), located in coding exon 1 of the ACTN2 gene, results from a G to T substitution at nucleotide position 22. The valine at codon 8 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.33
CADD
Uncertain
25
DANN
Uncertain
0.98
DEOGEN2
Benign
0.29
.;T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.37
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.77
T;T
M_CAP
Pathogenic
0.65
D
MetaRNN
Benign
0.19
T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
1.6
L;L
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-0.020
N;N
REVEL
Benign
0.20
Sift
Benign
0.58
T;T
Sift4G
Benign
0.84
T;T
Polyphen
0.0020
.;B
Vest4
0.081
MutPred
0.18
Loss of loop (P = 0.0986);Loss of loop (P = 0.0986);
MVP
0.64
MPC
0.84
ClinPred
0.19
T
GERP RS
2.8
Varity_R
0.076
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs551141480; hg19: chr1-236849995; API